Cargando…

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease

Subthalamic nucleus deep brain stimulation (STN-DBS) improves motor symptoms in individuals with advanced Parkinson’s disease (PD) and enables physicians to reduce doses of antiparkinsonian drugs. We investigated possible predictive factors for the successful reduction of antiparkinsonian drug dosag...

Descripción completa

Detalles Bibliográficos
Autores principales:	SAMURA, Kazuhiro, MIYAGI, Yasushi, KAWAGUCHI, Minako, YOSHIDA, Fumiaki, OKAMOTO, Tsuyoshi, KAWASHIMA, Masatou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Neurosurgical Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753254/ https://www.ncbi.nlm.nih.gov/pubmed/31231086 http://dx.doi.org/10.2176/nmc.oa.2019-0040

Ejemplares similares

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Development of Quality of Life Questionnaire for Patients with Parkinson’s Disease Undergoing STN-DBS
por: KAWAGUCHI, Minako, et al.
Publicado: (2021)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
por: Silva, Sara, et al.
Publicado: (2021)

A STUDY OF PROPHYLACTIC VALUE OF ANTIPARKINSONIAN DRUG
por: Behere, P.B., et al.
Publicado: (1983)

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication
por: Chung, Jae Woo, et al.
Publicado: (2017)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs
por: Taguchi, Soutarou, et al.
Publicado: (2019)

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
por: Nimmons, Danielle, et al.
Publicado: (2021)

Premature drug reduction after subthalamic nucleus deep brain stimulation leading to worse depression in patients with Parkinson's disease
por: Diao, Yu, et al.
Publicado: (2023)

Adjustment of Subthalamic Deep Brain Stimulation Parameters Improves Wheeze and Dyspnea in Parkinson's Disease
por: Komiya, Hiroyasu, et al.
Publicado: (2019)

Emergent Carotid Artery Stenting Following Intravenous Alteplase Infusion After Rapid Negative Diagnosis for COVID-19 by Loop-Mediated Isothermal Amplification Assay
por: Michiwaki, Yuhei, et al.
Publicado: (2021)

Delayed Onset Eye Opening Apraxia due to Progression of Brain Atrophy following Subthalamic Nucleus Deep Brain Stimulation: A Case Report
por: Morishita, Takashi, et al.
Publicado: ( 201)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Pulse duration settings in subthalamic stimulation for Parkinson's disease
por: Steigerwald, Frank, et al.
Publicado: (2017)

Subthalamic and Pallidal Deep Brain Stimulation for Parkinson’s Disease
por: Negida, Ahmed, et al.
Publicado: (2018)

Subthalamic stimulation changes motor laterality in Parkinson’s disease
por: Lin, Zhengyu, et al.
Publicado: (2020)

Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation
por: Lau, Brian, et al.
Publicado: (2019)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
por: Massari, Caio M., et al.
Publicado: (2017)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
por: Paccione, Nicola, et al.
Publicado: (2022)

Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization
por: Arulkumar, Subramanian, et al.
Publicado: (2010)

Optimal target localization for subthalamic stimulation in patients with Parkinson disease
por: Welter, Marie-Laure, et al.
Publicado: (2014)

Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
por: Kim, Han-Joon, et al.
Publicado: (2015)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease
por: Pflug, Christina, et al.
Publicado: (2020)

Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease
por: Brezovar, Simon, et al.
Publicado: (2022)

No effect of subthalamic deep brain stimulation on metacognition in Parkinson’s disease
por: Trenado, Carlos, et al.
Publicado: (2023)

Remote programming for subthalamic deep brain stimulation in Parkinson's disease
por: Chen, Si, et al.
Publicado: (2022)

Predict initial subthalamic nucleus stimulation outcome in Parkinson's disease with brain morphology
por: Chen, Yingchuan, et al.
Publicado: (2022)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

Real-Time Neurofeedback to Modulate β-Band Power in the Subthalamic Nucleus in Parkinson’s Disease Patients
por: Fukuma, Ryohei, et al.
Publicado: (2018)

Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease
por: Eusebio, Alexandre, et al.
Publicado: (2008)

Effects of Subthalamic Nucleus Stimulation on Emotional Prosody Comprehension in Parkinson's Disease
por: Brück, Carolin, et al.
Publicado: (2011)

Factors Related to Outcomes of Subthalamic Deep Brain Stimulation in Parkinson's Disease
por: Kim, Hae Yu, et al.
Publicado: (2013)

Effect of Subthalamic Stimulation on Voice and Speech in Parkinson’s Disease: For the Better or Worse?
por: Skodda, Sabine, et al.
Publicado: (2014)

Impact of Bilateral Subthalamic Stimulation on Motor/Cognitive Functions in Parkinson's Disease
por: ASAHI, Takashi, et al.
Publicado: (2014)

Subthalamic nucleus stimulation impairs emotional conflict adaptation in Parkinson’s disease
por: Irmen, Friederike, et al.
Publicado: (2017)

The Study of Subthalamic Deep Brain Stimulation for Parkinson Disease-Associated Camptocormia
por: Liang, Siquan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_225v693js7vp7q2uon7nn717cs